Annovis Bio, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Annovis Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $16.29K.
- Annovis Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $1.00K.
- Annovis Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $7.39K, a 60.11% increase year-over-year.
- Annovis Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $4.61K, a 52.90% increase year-over-year.
- Annovis Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $2.00K.
- Annovis Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $8.38K, a 81.77% increase from fiscal 2022.
- Annovis Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $4.61K, a 95.15% decline from fiscal 2021.
- Annovis Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $95.10K, a 931.81% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $16.29K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $2.00K 10-K · filed 2026-03-13 | |
| 2023-12-31 | $8.38K 10-K · filed 2025-03-21 | |
| 2023-06-30 | $1.00K 10-Q · filed 2024-11-08 | |
| 2023-03-31 | $7.39K 10-Q · filed 2024-11-08 | |
| 2022-12-31 | $4.61K 10-K · filed 2024-03-29 | |
| 2022-03-31 | $4.61K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $95.10K 10-K · filed 2023-03-31 | |
| 2021-06-30 | $92.08K 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $3.02K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $9.22K 10-K · filed 2022-03-02 | |
| 2020-06-30 | $4.61K 10-Q · filed 2021-11-03 | |
| 2020-03-31 | $4.61K 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |